Top drugs by total member spend
Highest class projected price change
DMARDs projected inflation rate is 4.7%
Price increases are anticipated for the high-cost drugs Adalimumab and Etanercept due to delays in bringing biosimilars to market.
New! Diabetes-related medication analysis
2.63% projected inflation rate
Insulins are now classified as biologics, opening the door for biosimilars and interchangeable biologics competition.
Moving pharmacy forward
Learn about our Pharmacy Program. We are here to support you.